BMY vs IBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

BMY

48.1
AI Score
VS
BMY Wins

IBIO

45.7
AI Score

Investment Advisor Scores

BMY

48score
Recommendation
HOLD

IBIO

46score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric BMY IBIO Winner
Forward P/E 9.3721 0 Tie
PEG Ratio 17.041 0 Tie
Revenue Growth 6.9% -100.0% BMY
Earnings Growth -2.8% 0.0% IBIO
Tradestie Score 48.1/100 45.7/100 BMY
Profit Margin 18.5% 0.0% BMY
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY IBIO

Relative Price Performance (Last 90 Days)

BMY 1M: +11.0% · 3M: -2.7% IBIO 1M: +5.4% · 3M: -41.1%

Current Technical Phase

BMY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 54.0 · Price: $62.91

IBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.8 · Price: $0.82

Fundamentals Snapshot

Metric BMY IBIO
Market Cap — —
Forward P/E 9.4 -2.7
Trailing P/E 13.9 —
Revenue (TTM) — —
Revenue Growth 0.1% -1.0%
Gross Margin 0.7% 1.0%
Operating Margin 0.3% -301.4%
EPS 4.51 -0.32
Dividend Yield 0.04% —

Frequently Asked Questions

Based on our detailed analysis, BMY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.